163 related articles for article (PubMed ID: 35765089)
1. PITX2C increases the stemness features of hepatocellular carcinoma cells by up-regulating key developmental factors in liver progenitor.
Jiang L; Wang X; Ma F; Wang X; Shi M; Yan Q; Liu M; Chen J; Shi C; Guan XY
J Exp Clin Cancer Res; 2022 Jun; 41(1):211. PubMed ID: 35765089
[TBL] [Abstract][Full Text] [Related]
2. RALYL increases hepatocellular carcinoma stemness by sustaining the mRNA stability of TGF-β2.
Wang X; Wang J; Tsui YM; Shi C; Wang Y; Zhang X; Yan Q; Chen M; Jiang C; Yuan YF; Wong CM; Liu M; Feng ZY; Chen H; Ng IOL; Jiang L; Guan XY
Nat Commun; 2021 Mar; 12(1):1518. PubMed ID: 33750796
[TBL] [Abstract][Full Text] [Related]
3. Differential expression and functional analysis of Pitx2 isoforms in regulation of heart looping in the chick.
Yu X; St Amand TR; Wang S; Li G; Zhang Y; Hu YP; Nguyen L; Qiu MS; Chen YP
Development; 2001 Mar; 128(6):1005-13. PubMed ID: 11222154
[TBL] [Abstract][Full Text] [Related]
4. Mesendoderm and left-right brain, heart and gut development are differentially regulated by pitx2 isoforms.
Essner JJ; Branford WW; Zhang J; Yost HJ
Development; 2000 Mar; 127(5):1081-93. PubMed ID: 10662647
[TBL] [Abstract][Full Text] [Related]
5. ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation.
Lin Q; Wu Z; Yue X; Yu X; Wang Z; Song X; Xu L; He Y; Ge Y; Tan S; Wang T; Song H; Yuan D; Gong Y; Gao L; Liang X; Ma C
EBioMedicine; 2020 Mar; 53():102676. PubMed ID: 32114388
[TBL] [Abstract][Full Text] [Related]
6. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
[TBL] [Abstract][Full Text] [Related]
7. Tonicity-responsive enhancer-binding protein promotes stemness of liver cancer and cisplatin resistance.
Lee JH; Suh JH; Kang HJ; Choi SY; Jung SW; Lee-Kwon W; Park SA; Kim H; Ye BJ; Yoo EJ; Jeong GW; Park NH; Kwon HM
EBioMedicine; 2020 Aug; 58():102926. PubMed ID: 32739873
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
9. Silencing of long noncoding RNA HOXA11-AS inhibits the Wnt signaling pathway via the upregulation of HOXA11 and thereby inhibits the proliferation, invasion, and self-renewal of hepatocellular carcinoma stem cells.
Guo JC; Yang YJ; Zheng JF; Zhang JQ; Guo M; Yang X; Jiang XL; Xiang L; Li Y; Ping H; Zhuo L
Exp Mol Med; 2019 Nov; 51(11):1-20. PubMed ID: 31757938
[TBL] [Abstract][Full Text] [Related]
10. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
[TBL] [Abstract][Full Text] [Related]
11. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
[TBL] [Abstract][Full Text] [Related]
12. Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway.
Li B; Cao Y; Meng G; Qian L; Xu T; Yan C; Luo O; Wang S; Wei J; Ding Y; Yu D
EBioMedicine; 2019 Jan; 39():239-254. PubMed ID: 30555042
[TBL] [Abstract][Full Text] [Related]
13. Pitx2c overexpression promotes cell proliferation and arrests differentiation in myoblasts.
Martínez-Fernandez S; Hernández-Torres F; Franco D; Lyons GE; Navarro F; Aránega AE
Dev Dyn; 2006 Nov; 235(11):2930-9. PubMed ID: 16958127
[TBL] [Abstract][Full Text] [Related]
14. TLR4 increases the stemness and is highly expressed in relapsed human hepatocellular carcinoma.
Zhou S; Du R; Wang Z; Shen W; Gao R; Jiang S; Fang Y; Shi Y; Chang A; Liu L; Liu C; Li N; Xiang R
Cancer Med; 2019 May; 8(5):2325-2337. PubMed ID: 30957973
[TBL] [Abstract][Full Text] [Related]
15. Cellular retinol binding protein-1 inhibits cancer stemness via upregulating WIF1 to suppress Wnt/β-catenin pathway in hepatocellular carcinoma.
Liu X; Shan W; Li T; Gao X; Kong F; You H; Kong D; Qiao S; Tang R
BMC Cancer; 2021 Nov; 21(1):1224. PubMed ID: 34775955
[TBL] [Abstract][Full Text] [Related]
16. Tbx1 regulates progenitor cell proliferation in the dental epithelium by modulating Pitx2 activation of p21.
Cao H; Florez S; Amen M; Huynh T; Skobe Z; Baldini A; Amendt BA
Dev Biol; 2010 Nov; 347(2):289-300. PubMed ID: 20816801
[TBL] [Abstract][Full Text] [Related]
17. LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3.
Shu G; Su H; Wang Z; Lai S; Wang Y; Liu X; Dai L; Bi Y; Chen W; Huang W; Zhou Z; He S; Dai H; Tang B
J Exp Clin Cancer Res; 2021 Jan; 40(1):45. PubMed ID: 33499874
[TBL] [Abstract][Full Text] [Related]
18. Tex10 is upregulated and promotes cancer stem cell properties and chemoresistance in hepatocellular carcinoma.
Xiang X; Deng L; Xiong R; Xiao D; Chen Z; Yang F; Liu K; Feng G
Cell Cycle; 2018; 17(11):1310-1318. PubMed ID: 30045663
[TBL] [Abstract][Full Text] [Related]
19. Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma.
Liu B; Fang X; Kwong DL; Zhang Y; Verhoeft K; Gong L; Zhang B; Chen J; Yu Q; Luo J; Tang Y; Huang T; Ling F; Fu L; Yan Q; Guan XY
J Exp Clin Cancer Res; 2022 May; 41(1):182. PubMed ID: 35610614
[TBL] [Abstract][Full Text] [Related]
20. Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma.
Cheng SW; Tsai HW; Lin YJ; Cheng PN; Chang YC; Yen CJ; Huang HP; Chuang YP; Chang TT; Lee CT; Chao A; Chou CY; Chan SH; Chow NH; Ho CL
PLoS One; 2013; 8(11):e80053. PubMed ID: 24244607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
